Published in In Vivo on November 07, 1991
Expression of differentiated functions in mouse neuroblastoma mediated by dibutyryl-cyclic adenosine monophosphate. Nature (1971) 1.87
A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods (1987) 1.52
Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature (1995) 1.48
NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. Biochim Biophys Acta (1984) 1.31
Prognostic value of estrogen receptor determinations in patients with breast cancer. Cancer Res (1978) 1.29
Growth of Escherichia coli on fatty acids: requirement for coenzyme A transferase activity. Biochem Biophys Res Commun (1968) 1.08
Inhibition by 2',3'-dideoxythymidine of retroviral infection of mouse and human cells. Cancer Lett (1980) 1.08
The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update. Cancer (1980) 1.08
Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res (1994) 1.05
Growth of human mammary epithelial cells on collagen gel surfaces. Cancer Res (1981) 0.99
Cell surface interactions with concanavalin A. Location of bound radiolabeled lectin. Exp Cell Res (1974) 0.97
Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors. Cancer Res (1988) 0.94
Concanavalin A-mediated hemadsorption by normal and malignant human mammary epithelial cells. Cancer Res (1978) 0.94
Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture. J Cell Biol (1980) 0.93
Growth of normal and malignant human mammary epithelial cells in culture. J Natl Cancer Inst (1979) 0.92
Selection of mutants constitutive for several glyoxylate condensing enzymes during growth on valeric acid. Biochim Biophys Acta (1967) 0.91
Infection of macrophages with Friend virus: relationship to the spontaneous regression of viral erythroleukemia. Cell (1979) 0.90
Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression. J Immunol (1978) 0.90
The cell kinetics of human mammary cancers. Cancer (1979) 0.88
Proliferative defects in renal and intestinal epithelium after cis-dichlorodiammine platinum (II). Br J Cancer (1982) 0.88
High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier. Biochim Biophys Acta (1986) 0.88
Effect of dexamethasone on vascular function in RIF-1 tumors. Cancer Res (1986) 0.87
Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol (1999) 0.87
Normal human mammary cells in culture: evidence for oncornavirus-like particles. J Natl Cancer Inst (1974) 0.87
The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation. Magn Reson Imaging (1986) 0.86
Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes. Cancer Res (1986) 0.86
A murine model system for the study of the human leukemia-associated inhibitory activity. Blood (1980) 0.86
Effects of dimethylsulfoxide on expression of differentiated functions in mouse neuroblastoma. J Natl Cancer Inst (1972) 0.86
1H-NMR relaxation times and water compartmentalization in experimental tumor models. Magn Reson Imaging (1986) 0.86
Prognostic value of concanavalin A reactivity of primary human breast cancer cells. Cancer Res (1981) 0.86
In vitro labeling and gold activation autoradiography for determination of labeling index and DNA synthesis times of solid tumors. Cancer Res (1976) 0.86
Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors. Cancer Res (1978) 0.85
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy. Melanoma Res (1998) 0.85
Function of the glyoxylate-condensing enzymes. I. Growth of Escherichia coli on n-valeric acid. J Bacteriol (1967) 0.85
Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells. J Natl Cancer Inst (1978) 0.85
Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. Magn Reson Med (1991) 0.84
Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity. Exp Hematol (1991) 0.84
Interleukin-1 alpha-induced tumour pathophysiologies can be exploited with bioreductive alkylating agents. Int J Radiat Biol (1991) 0.84
Identification and isolation of the major core protein from the oncornavirus-like particle in human milk. Cancer Res (1976) 0.83
31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors. Cancer Res (1989) 0.82
Adriamycin-induced delayed erythropoietic injury expressed following anemia stress. Cancer Res (1980) 0.82
Cell fusion in tumor development and progression: occurrence of cell fusion in primary methylcholanthrene-induced tumorigenesis. Int J Cancer (1989) 0.81
Spontaneous regression of friend virus induced leukemia: coinfection with regressing and conventional strains of virus. Science (1975) 0.81
Effect of the extracellular matrix on plasminogen activator isozyme activities of human mammary epithelial cells in culture. Mol Cell Biol (1983) 0.81
Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy. Cancer Treat Rep (1980) 0.80
In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). Exp Hematol (1990) 0.80
In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications. Blood (1988) 0.80
Effects of thymectomy and antithymocyte serum on spontaneous regression of Friend virus-induced erythroleukemia. J Natl Cancer Inst (1976) 0.79
Iron-induced conformational change in human lactoferrin: demonstration by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analysis of effects of iron binding to the N and C lobes of the molecule. Electrophoresis (1994) 0.79
Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice. Leukemia (1989) 0.79
Differentiation of normal human mammary epithelial cells in culture: an ultrastructural study. Am J Anat (1976) 0.79
Inhibition of normal erythropoiesis in mice with Friend virus induced erythroleukemia. Exp Hematol (1982) 0.79
Absence of tumorigenicity in athymic mice by normal human epidermal keratinocytes after culture in serum-free medium. Cancer Lett (1992) 0.79
Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer. Clin Cancer Res (1998) 0.79
Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int J Radiat Oncol Biol Phys (1993) 0.79
Anemic stress as a trigger of myelogenous leukemia in the unirradiated RF mouse. Science (1972) 0.78
Mechanism of macrophage reversal of Friend erythroleukemia: macrophage regulation of normal and leukemic erythropoiesis. Cancer Res (1986) 0.78
Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors. Cancer Lett (1990) 0.78
Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor. J Natl Cancer Inst (1991) 0.78
Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study. J Nucl Med (1993) 0.77
Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper murine leukemia virus component. J Exp Med (1977) 0.77
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model. Cancer Res (1994) 0.77
Cell surface interactions with concanavalin A: determination by microhemadsorption. Proc Soc Exp Biol Med (1972) 0.77
Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole. Cancer Res (1990) 0.77
Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice. Cancer Chemother Pharmacol (1993) 0.77
Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols. Bioorg Med Chem Lett (1999) 0.77
Receptor-dependent antiproliferative effects of corticosteroids in radiation-induced fibrosarcomas and implications for sequential therapy. Cancer Res (1982) 0.76
The cytokinetic basis for the design of efficacious radiotherapy protocols. Int J Radiat Oncol Biol Phys (1979) 0.76
Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha. Cancer Res (1991) 0.76
Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors. Cancer Res (1980) 0.76
Role of corticosteroid hormones in the control of cell proliferation in residual tumor after surgical cytoreduction. Cancer Res (1983) 0.76
Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments. Br J Cancer (1982) 0.75
Spontaneous regression of Friend virus-induced erythroleukemia. VI. Structural and antigenic differences between the regressing and conventional strains of virus. J Virol (1980) 0.75
The effect of adrenalectomy and dexamethasone on interleukin-1 alpha induced responses in RIF-1 tumours. Br J Cancer (1990) 0.75
Spontaneous regression of Friend virus-induced erythroleukemia IX. Role of complement in leukemia regression. Leuk Res (1982) 0.75
DNA-dependent-DNA-polymerase: possible limiting influence on cell reproduction during viral leukemogenesis. Experientia (1978) 0.75
Induction of lactoferrin expression in murine ES cells by retinoic acid and estrogen. Exp Cell Res (1998) 0.75
An analysis of factors associated with non-compliance with follow-up recommendations after a positive fecal occult blood test. Prog Clin Biol Res (1989) 0.75
Rapid methods for utilizing cell kintics for treatment in the C3H/He spontaneous mammary tumor: effects of vincristine. Cancer Treat Rep (1976) 0.75
Infection of haematopoietic stem cells in mice with Friend virus induced erythroleukaemia. Cell Tissue Kinet (1986) 0.75
Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system. Cancer Res (1990) 0.75
Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody. Adv Exp Med Biol (1994) 0.75
Effects of inhibitors and activators of protein kinase C on late erythroid progenitor (CFU-e) colony formation in vitro. Int J Cell Cloning (1989) 0.75
Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignancies. J Immunother (1998) 0.75
Cell kinetics after vincristine treatment of C3H/He spontaneous mammary tumors: implications for therapy. J Natl Cancer Inst (1978) 0.75
Effect of high-dose, fractionated local irradiation on MNU-induced carcinogenesis in the rat mammary gland. Carcinogenesis (1995) 0.75
Results of a community-based breast cancer screening program. Prog Clin Biol Res (1989) 0.75
Effect of C-reactive protein on granulocyte-macrophage progenitor cells. J Lab Clin Med (1982) 0.75
Cell kinetics in vivo and in vitro for C3H/He spontaneous mammary tumors. J Natl Cancer Inst (1977) 0.75
Inhibition of CFU-E colony formation by resident peritoneal macrophages from hybrids of BALB/c mice. J Leukoc Biol (1984) 0.75
Nuclear DNA polymerase-alpha and replicative potential in mammalian cells. Eur J Cancer (1977) 0.75
Tumor cell population kinetics following noncurative treatment. Antibiot Chemother (1971) (1978) 0.75
Stimulation of normal erythropoiesis in vitro by macrophages from erythroleukemic mice. J Natl Cancer Inst (1984) 0.75
The effect of continuous infusion IL-1 alpha on carboplatin-induced thrombocytopenia and anti-tumor activity in RIF-1 tumor bearing mice. Oncol Rep (2011) 0.75
Dose determination in high dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (1992) 0.75
Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts. Cancer Res (2001) 0.75